Health
Simple blood test diagnoses Parkinson's disease long before symptoms appear — A new research report appearing in the December issue of the FASEB Journal (http://www.fasebj.org) shows how scientists from the United Kingdom have developed a simple blood test to…
Early sign of Alzheimer's reversed in lab — One of the earliest known impairments caused by Alzheimer's disease - loss of sense of smell - can be restored by removing a plaque-forming protein in a mouse model of the disease,…
Parental controls on embryonic development? — When a sperm fertilises an egg, each contributes a set of chromosomes to the resulting embryo, which at these very early stages is called a zygote. Early on, zygotic genes are inert,…
Newly discovered heart stem cells make muscle and bone — Researchers have identified a new and relatively abundant pool of stem cells in the heart. The findings in the December issue of Cell Stem Cell, a Cell Press publication, show that…
BUSM researchers develop blood test to detect membranous nephropathy — Research conducted by a pair of physicians at Boston University School of Medicine (BUSM) and Boston Medical Centre (BMC) has led to the development of a test that can help diagnose…
New hip implants no better than traditional implants — New hip implants appear to have no advantage over traditional implants, suggests a review of the evidence published on bmj.com today…
Action needed to improve men's health in Europe — Policies aimed specifically at men are urgently needed to improve the health of Europe's men, say experts on bmj.com today…
Probiotics reduce infections for patients in intensive care — Traumatic brain injury is associated with a profound suppression of the patient's ability to fight infection. At the same time the patient also often suffers hyper-inflammation, due…
High blood sugar levels in older women linked to colorectal cancer — Elevated blood sugar levels are associated with an increased risk of colorectal cancer, according to a study led by researchers at Albert Einstein College of Medicine of Yeshiva University.…
Engineered botulism toxins could have broader role in medicine — The most poisonous substance on Earth - already used medically in small doses to treat certain nerve disorders and facial wrinkles - could be re-engineered for an expanded role in helping…
Where am I? > Home > News > Health

VEGF-B helps nerve cells cheat death without unwanted side effects

Science Centric | 8 February 2008 14:31 GMT
Printable version A clip for your blog or website E-mail the story to a friend
Bookmark or share the story on your social network Vote for this article Decrease text size Increase text size
DON'T MISS —
Cancer: The cost of being smarter than chimps?
Cancer: The cost of being smarter than chimps? — Are the cognitively superior brains of humans, in part, responsible for our higher rates of cancer? That's a question that…
Study gives clues to how adrenal cancer forms
Study gives clues to how adrenal cancer forms — At the ends of chromosome are special pieces of DNA called telomeres. Think of it as the little tip that caps off a shoelace.…
More Health

The prototypical member of the VEGF family of proteins, VEGF, has recently been shown to protect cells in the nervous system from death and degeneration. However, its clinical utility in this regard is limited, because it also induces blood vessel growth, a process known as angiogenesis. In a new study, Xuri Li and colleagues at the National Institutes of Health, Bethesda, have revealed that the VEGF family member VEGF-B acts as a potent inhibitor of murine retinal cell death while exerting minimal angiogenic effects.

In addition to inhibiting expression of cell-death - related genes, VEGF-B was shown to reduce the death of murine retinal cells in culture models of cellular injury and in mouse models of ocular neurodegenerative disorders. Furthermore, VEGF-B treatment inhibited brain cell death in a mouse model of stroke. As the concentration of VEGF-B required for retinal protection did not lead to angiogenesis in the mouse retina, the authors concluded that VEGF-B might provide a new therapeutic option for the treatment of neurodegenerative disease.

Source: Journal of Clinical Investigation


Leave a comment
The details you provide on this page [e-mail address] will not be used to send unsolicited e-mail, and will not be supplied to a third party! Please note that we can not promise to give everyone a response. Comments are fully moderated. Once approved they will be posted within 24 hours.
Expand the form to leave a comment

RSS FEEDS, NEWSLETTER
Find the topic you want. Science Centric offers several RSS feeds for the News section.

Or subscribe for our Newsletter, a free e-mail publication. It is published practically every day.

New centre aims to improve recovery of soldiers with severe injuriesNew centre aims to improve recovery of soldiers with severe injuries

— When a soldier is wounded during combat, surgeons must focus on reducing infection and reconstructing damaged bone and tissues. Technologies that could improve the…

Products may revolutionise how men monitor their reproductive statusProducts may revolutionise how men monitor their reproductive status

— A medical home test kit based on a protein discovered at the University of Virginia Health System - SpermCheck Vasectomy - has begun shipping to zip codes across…

'Whose turn to pay?' can be deal-breaker for cohabiting couples'Whose turn to pay?' can be deal-breaker for cohabiting couples

— Couples living together face dozens of spending decisions every week. Should we eat out tonight? Whose turn to pay? Should we hire a lawnmower or a house cleaner,…

OSU to study air pollutant's impact on Chinese, U.S. healthOSU to study air pollutant's impact on Chinese, U.S. health

— Scientists at Oregon State University and China's Peking University plan to use part of a $12.4 million grant to study the impact that the burning of fuels like…

Popular tags in Health: cancer · diabetes · malaria · obesity